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Introduction
Epilepsy is one of the commonest non-communicable neurological disorders, 
resulting from a variety of causes, a number of  which are preventable or 
modifiable. It is an important cause of disability and mortality, and affects 
an estimated 70 million people worldwide.[1] However, epilepsy is more than 
a neurological dysfunction of the brain. Psychological, cognitive and socio-
economic consequences impact severely on quality of life.[2] In South Sudan there 
are many potentially modifiable risk factors. Some are ubiquitous in low-income 
countries and directly associated with resource and infrastructure issues of the 
local healthcare system. Examples of these risk factors are birth asphyxia, head 
injuries, infections  and stroke. Other causes are more specific for the region such 
as Onchocerciasis Associated Epilepsy.[3] This is an as yet unelucidated form of 
epilepsy occurring in areas with blackfly breeding sites, being fast flowing rivers, 
where settlers incur onchocerciasis infection and have a higher occurrence of 
seizures. The mechanism appears to be an interplay of inflammation and (epi)
genetic factors.[3] Some aetiologies of epilepsy are structural and/or genetic with 
no demonstrable risk factor.
Epilepsy in sub-Sahara Africa
The prevalence of epilepsy in sub-Sahara Africa (SSA) seems greater than in high 
income countries, but studies of community-based prevalence are limited. 
Uneven infrastructure in the health sector leads to a wide disparity in the  provision 
of medicines between urban and rural areas. Health  facilities for managing 
epilepsy in Juba are not replicated  in rural areas with the consequence that many 
people  with epilepsy  remain undiagnosed and  untreated. This epilepsy treatment 
gap [1] amounts to about 75% in most of SSA. The burden of neurological disease 
in Juba Teaching Hospital (JTH) was estimated from a sample of 124 patients in 
a thesis from 2014[4] to be 10%. This was a retrospective hospital-wide medical 
records study. The 10% (13/124 patients) prevalence might therefore be an under 
estimate compared with  the estimated 20% reported in an Internal Medicine in-
patient population study  in Northern Tanzania.[2]
The obstacles to recognition of epilepsy as a chronic neurological condition 
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Abstract
Epilepsy is usually a chronic condition. In many regions of the world care is 
compromised by limited recognition, access to medication and stigma. Quality 
of life for people with epilepsy and their families can improve substantially 
when seizures are recognised and better control instituted with the appropriate 
medication. Recognition and classification of seizures, coupled with evidence-
based and rational pharmacological management, can help resolve the many 
issues around this chronic neurological condition. 
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are many and include stigma, misconceptions about the 
condition, superstition and fear. These factors  all limit 
access to first line healthcare facilities. Most semirural and 
urban dispensaries will have access to the easily available 
and cheap antiepileptic drug (AED), phenobarbital. So, 
once epilepsy has been recognised the first-line treatment 
with phenobarbital can be given and a high proportion of 
people have been shown to  respond to this medication. 
However, follow up of people with epilepsy (PWE) has 
often not been possible due to poor record keeping and 
the long distances patients have to travel to see a healthcare 
professional. This means that young PWE might lapse 
into severe epilepsy having outgrown their dosage due to 
a higher body weight and run out of their initial course of 
medicines. It is often assumed that the prescribed course 
of the initial medication may be all that is required and 
prescriptions may not be renewed once the medicine runs 
out.
In those patients without a defined cause for their epilepsy, 
such as  infection or tumour, knowledge about medication 
regimens, drug interactions and phasing out protocols can 
make all the difference to their  quality of life. The prime 
purpose of this paper is to provide practical guidelines 
for recognition and prescription of  first- and second-line 
drug  treatment for seizure disorders. No patient related 
data were used for this practical review. 
Inadequate perinatal care, malnutrition, endemic 
infections (ranging from malaria to locally occurring 
onchocerciasis.[2]), the hazards of road  traffic accidents 
and violence all contribute to a high burden of epilepsy 
in SSA.[5] It is a region poorly equipped to deal with the 
diagnostic and therapeutic challenges due to inadequate 
healthcare infrastructure, social security and financial 
constraints. The stigma associated with epilepsy is a further 
obstacle to receipt of  regular anti-epileptic medication 
with many people opting for traditional medicine or 
reliance on prayer only. It has been shown in SSA that the 
treatment gap can be reduced once the facilities are made 
available to healthcare workers and to PWE[6] coupled 
with health  education.
The South Sudanese region within sub-Sahara Africa
The health system in South Sudan has three tiers: Primary 
Health Care Units, Primary Health Care Centres and 
Hospitals (which exist at state or  county levels and as 
police or military health facilities).These  are intended 
to deliver first- and second- line care for PWE. The 
Basic Package of Health Services covers preventive, 
curative, health promotion and managerial activities and 
is financed by the government with contributions from 
non-governmental organisations. These health facilities 
are meant to provide free healthcare to the majority of the 
population at the primary and secondary levels. Specialised 
care for PWE is available at JTH, South Sudan’s tertiary 
care facility. Unfortunately, computed tomographic (CT) 
scanning is not available at the JTH, but may be accessed 
at a cost to the patients at the neighbouring Juba Medical 
Complex, a private hospital. Rehabilitation services and 
special needs schools are available  in the private sector, 
but not provided as part of the services at JTH. 
Practical guidelines for recognising and treating 
seizure disorders
Diagnosis
The International League Against Epilepsy (ILAE) 
classification is used worldwide.[6] It is based on 
history and physical examination. Seizure observation 
is important with reports from eye witnesses. The 
detection of underlying causes of a seizure, such as focal 
brain abnormalities or infection, is crucial and usually 
Table 1.  Features of a typical seizure
• Duration attack itself: usually less than five minutes
• Can be stereotypical: recuring in a same recognisable sequence of signs and symptoms.
• Short aura: possible
• Generalised Tonic Clonic Seizures (GTCS): starting with cry, tonic phase with apnoea, clonic phase with 
involvement of all limbs, postictal sedation 
• Eyes are usually open in GTCS due to contraction of the facial musculature, and not closed until the 
postictal phase
• Tongue bite (lateral>anterior)
• Injuries (cuts, bruises, broken teeth, broken bones)  
• Incontinence (in case of full bladder/bowel)
• Amnesia for attack when generalised
• Postictal coma, sleepiness, confusion, myalgia, fatigue, malaise (up to 24 hours)
• Complex partial, frontal seizures can present with automatisms and dystonic arm posturing
• Go to great lengths for eyewitness account
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requires neuroimaging and laboratory tests. However, 
while awaiting these investigations, seizures should be 
treated with AEDs. Therefore, clinical classification is 
essential. Classification has been described elsewhere.[7] 
Mimics of epileptic seizures such as convulsive syncope 
or psychogenic attacks can cause diagnostic confusion.[8] 
Features of typical seizures versus features of conditions 
which may not be epileptic are summarised in Tables 1 
and 2 respectively. 
The ILAE classification comprises three steps of increasing 
complexity dependent on available resources. The first 
step is the most important one for the low resource 
setting where clinical assessment and history taking 
largely determine management. seizure type at onset: 
focal, generalised or unknown. Generalised convulsive 
seizures may be generalised from the onset (generalised 
tonic-clonic seizures) or focal at onset but generalised later 
(focal to bilateral tonic clonic). A focal onset may not be 
clinically evident. Non-convulsive seizures can be focal 
or generalised but they are different and often clinically 
subtle, such as myoclonic and absences. The second and 
third steps are more detailed and not relevant outside the 
area of epilepsy neurology, and epilepsy research.  
Electro-encephalography (EEG) can be helpful in 
supporting a clinical suspicion of epilepsy and especially 
in suspected non-convulsive status epilepticus. Adequate 
treatment choices, however, can largely be made without 
the support of EEG which has a significant false negative 
rate. In any case availability and affordability are limited 
in the region. 
The AEDs which are available in South Sudan are 
phenobarbital, phenytoin, carbamazepine, and diazepam. 
More expensive and difficult to acquire AEDs are sodium 
valproate, lamotrigine, levetiracetam, pregabaline and 
might have to be ordered from Sudan, Uganda or Kenya.
A clinician’s overview of the most commonly used AEDs 
is given in Table 3.
Phenobarbital is by far the best available and affordable 
AED in most of the world. More modern AEDs with 
better side effect profiles are alternative but seizure control 
can be effective with phenobarbital. Phenobarbital is an 
AED for daily and long-term preventative use. This an 
important  message to convey to the patient as part of 
their health education. A clear explanation to the patient 
concerning compliance and benefits of medication is vital. 
A layperson cannot be assumed to understand treatment 
principles and should not be blamed for non-compliance. 
Treatment of epilepsy is not simply a short-term  course. 
For PWE, there are everyday hazards. Operating motorised 
instruments (e.g., a car, a wood saw), open cooking fires, 
handling small children, herding animals, fetching water at 
the riverside, swimming, climbing heights, crossing roads. 
Such risks affect everyday living and limit employment 
opportunities. It is the responsibility of the doctor to 
explore and explain these risks to PWE  and how to avoid 
them.
The wider perspective
Epilepsy can be a disabling condition, limiting  PWE from 
taking part in a normal working life or building up normal 
relations. Many goals with regards to primary prevention 
of epilepsy include risk management in perinatal care, 
rendering road traffic safer, controlling of  infectious 
diseases and reducing the effects of trauma to the head. 
However, even in the best controlled circumstances, 
PWE remain vulnerable due to the chronic nature of the 
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Table 2. Features of an atypical attack
• Ever-changing presentations
• Motionless/eyes closed from onset of attack
• Duration >10 minutes
• Can be interrupted (e.g., in infantile self-gratification behaviour)
• Never incontinence/tongue bite/injury
• Pale, sweating, nauseous, dizzy (vasovagal/hypoglycaemia/cardiac)
• Premonitory symptoms ‘long enough to seek a comfortable position
• Quick postictal recovery (BUT: often in frontal lobe epilepsy/absence seizures)
• Emotional, thrashing; pelvic thrusting; crying; whining; shouting
• Never eye-witnessed; solely patient’s own account
• Consistently in one setting (school, work or certain situations)
• ‘Patient benefit’ (teenagers, boarders, soldiers etc.)
• No response on adequately doses of AEDs
• ‘Fits’ happening right in front of the doctor 
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condition, associated neuropsychological impairments 
and stigma. Nevertheless, with proper management, even 
when the most modern AEDs and other facilities are 
unavailable, quality of life can be improved with adequate 
information about what the disorder is.
Lack  of AED for PWE and  poor long term drug 
adherence is a  concern. Shortage of medication may lead 
PWE to change the initially prescribed drugs  which may 
result in the destabilisation of  the control of  epilepsy. 
Education about epilepsy, training of medical and nursing 
professionals to manage epilepsy in South Sudan is the 
cornerstone for appropriate medical treatment and, 
ultimately, the acceptance of epilepsy as a condition 
compatible with normal life. The stigmatisation of 
epilepsy will be reduced or eliminated with appropriate 
education and adequate control of symptoms. Reduction 
in  complications of epilepsy such as injuries or death may 
motivate PWE and their caregivers to adhere to treatment 
and seek gainful employment. 
With rational prescribing of the  top three available 
medications: phenobarbital, phenytoin and carbamazepine 
for the majority of PWE in South Sudan, epilepsy can be 
better  controlled as well as more  acceptable in society.
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